Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05240807 · ClinicalTrials.gov registry record · NA

Clinical Impact of Cardiac Photon Counting CT

A NA study of Coronary Artery Disease, sponsored by Mayo Clinic.

Recruiting
Registry status
NA
Development phase
450
Enrollment target
1
Study location

NCT05240807 is a NA study of Coronary Artery Disease that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 450 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05240807, a NA study of Coronary Artery Disease, is actively recruiting participants, sponsored by Mayo Clinic.

RECRUITING
Registry status
NA
Development phase
450 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research trial is to determine whether images taken using a Photon Counting Detector CT scanner (PCD-CT) after the patient has received a drug that makes the heart work harder provide clinically important information about the severity of suspected coronary artery disease compared to CT imaging performed without using the drug that causes the heart to work harder.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Photon counting computed tomography (PC-CT)

Study Locations (1)

Minnesota

  • Boleyn Andrist - Eyota

Trial Details

FieldValue
Enrollment Target 450 participants
Start Date 2022-08-24
Est. Completion 2026-04-01
Phase NA

Sponsor

Mayo Clinic

2,844 total trials

What the Registry Record Tells You About NCT05240807

The ClinicalTrials.gov registry entry for NCT05240807 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 450 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (65% lower). The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 1 intervention - of which Photon counting computed tomography (PC-CT) is the first listed.

NCT05240807 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT05240807 about?

NCT05240807 is a clinical study titled "Clinical Impact of Cardiac Photon Counting CT". The purpose of this research trial is to determine whether images taken using a Photon Counting Detector CT scanner (PCD-CT) after the patient has received a drug that makes the heart work harder provide clinically important information about the severity of suspected coronary artery disease compare...

What is the current status of trial NCT05240807?

This trial is currently recruiting. It is a NA study. The enrollment target is 450 participants. The study started on 2022-08-24. Estimated completion is 2026-04-01.

What conditions does trial NCT05240807 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT05240807?

The interventions under investigation include: Photon counting computed tomography (PC-CT) (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05240807?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05240807 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.